A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT02233543 · COMPLETED
Trial details
- NCT number
- NCT02233543
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-30
- Primary completion
- 2016-06-26
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.